Human Papillomavirus Therapeutics Market Is Forecast to Reach US $2.34 Bn by the End of 2020
The global market for human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics is competitive in nature and is projected to witness a high level of competition in the next few years, states a new market research study by Transparency Market Research. Some of the key players operating in the market across the globe are Roche AG, Valeant Pharmaceuticals, Perrigo Company plc, Clinigen Group plc., Fougera Pharmaceuticals, and Fresenius Kabi USA. Among the mentioned players, the Roche AG is estimated to account...
View full press release